Redbiotec is pleased to welcome Prof. Maries van den Broek, PhD, Professor at the University of Zurich, Institute of Experimental Immunology, as an additional exclusive member of our Scientific Advisory Board. Maries is a renowned expert in the field of tumor immunology. The aim of her work is to better understand the mutual interaction between the immune system and cancer. Redbiotec looks forward to benefiting from this collaboration.
Redbiotec recently hired three additional scientists supporting Redbiotec’s fast growing oncology program. We are happy to observe a big and growing interest in Redbiotec’s COMOS and in Redbiotec’s engineered bacteria carrying CRISPR. As a consequence Redbiotec will invest further resources in these promising immuno-oncology platforms. Redbiotec is currently also evaluating additional people strengthening its scientific advisory board.
Redbiotec is currently engineering and producing a number of novel E. coli bacteria strains. These strains are expected to show superior features in Redbiotec’s COMOs and in further applications. Based on the current and upcoming results Redbiotec plans to file an additional patent application by Q4 2018.
Dani Arnold, one of world’s top mountaineers and climbers, world speed record holder of Matterhorn North Face (1h 46min), joins Redbiotec in its headquarters. In its over ten years since foundation the Redbiotec team climbed multiple Swiss mountains. Reaching out for summits and facing physical and mental challenges has always been one of Redbiotec’s passions. “We simply adore the mountains. They are beautiful, and beautiful things motivate”, Christian Schaub, CEO of Redbiotec says, “Our summer and winter trips into the Swiss Alpes inspire our team and make us robust for reaching our high goals in our labs. We are deeply honored that Dani Arnold shared his extraordinary and outstanding achievements with Redbiotec and even trained Redbiotec’s team in improving its climbing skills. We are very much looking forward to a hopefully long lasting partnership and are convinced Dani will further boost our exciting business and helps us setting our goals very high”.
“Redbiotec and I share the same values and mindset. We both want to have a big impact on our sectors. We both seek for the biggest challenges, we never give up, while always trying to stay humble“, Dani Arnold says. “I’m very proud of being part of Redbiotec’s story”.
Redbiotec has successfully upgraded its infrastructure adding additional labs to biosafety level 2 plus (BSL-2+). This is an important step for Redbiotec, as our company is now allowed, among others, to make all the needed genetic engineering of our bacteria of interest such as E. coli and Salmonella as well as oncolytic viruses in-house. Together with the ongoing fruitful partnerships with leading research organizations globally, Redbiotec has a strong position in combining microorganims to fight cancer. The main medical application of Redbiotec’s cancer program is to reduce cancer recurrences. Please find more information here.